• Australian (ASX) Stock Market Forum

Hello and welcome to Aussie Stock Forums!

To gain full access you must register. Registration is free and takes only a few seconds to complete.

Already a member? Log in here.

PKS - PKS Holdings

Discussion in 'Stocks I-P' started by System, May 13, 2019.

  1. System

    System Administrator

    Posts:
    2,431
    Likes Received:
    36
    Joined:
    Jun 27, 2010
    PKS is an Australian healthcare technology company that provides a proprietary subscription based Clinical Decision Support system (CDS) called "RippleDown". RippleDown automates the human decision-making process within healthcare organisations based on rules set within the organisation by domain experts.

    PKS' customers include laboratories, hospitals and other healthcare organisations and RippleDown was developed to address major issues within these organisations, including:
    • the increased financial pressures that are being faced;
    • a continual rise in patient volumes;
    • rising expectations for patient outcomes; and
    • succession risk from changes in personnel.
    The RippleDown CDS software consists of two separate products:
    • RippleDown Expert that has applications for the clinical side of a healthcare organisation's operations; and
    • RippleDown Auditor that has applications for the financial side of a healthcare organisation's operations.
    PKS distributes its products via two key channels, being direct sales using its own sales resources and through three global channel partners, being Abbott, Philips and Thermo Fisher. Sales through channel partners represented approximately 30% of total revenue in FY2018, which has grown from 10% of total revenue in FY2016.

    It is anticipated that PKS will list on the ASX during June 2019.

    https://pks.com.au
     

Share This Page